RMM23 is an inhibitor that targets PfBDP1, exhibiting a Kd of 1.24 µM. In vitro, it shows EC50 values of 18 µM against the 3D7 wild-type strain, 14 µM against the NF54 wild-type strain, and 20 µM against the multidrug-resistant K1 strain during the blood stage.
Target:
Epigenetic Reader Domain|||Parasite
* VAT and and shipping costs not included. Errors and price changes excepted
